Msi-H/DMMR gastric carcinoma and colorectal cancer

Clinical trials for Msi-H/DMMR gastric carcinoma and colorectal cancer explained in plain language.

Never miss a new study

Get alerted when new Msi-H/DMMR gastric carcinoma and colorectal cancer trials appear

Sign up with your email to follow new studies for Msi-H/DMMR gastric carcinoma and colorectal cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New antibody shows promise against tough cancers in early trial

Disease control Ongoing

This phase 2 study tests a drug called AK104, which helps the immune system attack cancer cells, in people with specific types of stomach or colorectal cancer. Participants receive the drug before and after surgery to see if it can completely eliminate the tumor. The trial involv…

Matched conditions: MSI-H/DMMR GASTRIC CARCINOMA AND COLORECTAL CANCER

Phase 2 • Sponsor: Peking University • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC

Msi-H/DMMR gastric carcinoma and colorectal cancer

Get alerted when new Msi-H/DMMR gastric carcinoma and colorectal cancer trials appear

New antibody shows promise against tough cancers in early trial